In light of human health concerns, an FDA panel of experts has rejected a proposal by the maker of a new antibiotic, Cefquinome, for selling the drug to treat respiratory disease in beef cattle. This decision was the first rejection of its kind by the FDA's Veterinary Medicine Advisory Committee (VMAC) and an important step towards protecting the efficacy of antibiotics in human medicine.